Just Published: "Genomic Health, Inc. (GHDX) - Product Pipeline Analysis, 2014 Update"
Genomic Health, Inc. (Genomic Health) is a life sciences company. It focuses on the research, development and commercialization of genomic-based clinical laboratory services for the treatment of cancer. The company's commercial product portfolio consists of Oncotype DX breast cancer test,Oncotype DX colon cancer test, and Oncotype DX prostate cancer test. Its product pipeline helps optimize the treatment of urologic cancers including prostate, bladder and kidney cancers, as well as additional treatment decisions in breast and colon cancers. Further, the company...
View full press release